RT Book, Section A1 Konradi, Christine A1 Hurd, Yasmin L. A2 Brunton, Laurence L. A2 Knollmann, Björn C. SR Print(0) ID 1193231828 T1 Drug Use Disorders and Addiction T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781264258079 LK accessmedicine.mhmedical.com/content.aspx?aid=1193231828 RD 2024/10/14 AB AbbreviationsΔ9-THC: Δ-9-tetrahydrocannabinolADHD: attention-deficit/hyperactivity disorderAIDS: acquired immune deficiency syndromeAUD: alcohol use disorderCBD: cannabidiolCDC: U.S. Centers for Disease Control and PreventionCRF: corticotropin-releasing factorCSA: Controlled Substances ActDA: dopamineDAT: dopamine transporterDEA: U.S. Drug Enforcement AdministrationDMT: dimethyltryptamineDSM-5:Diagnostic and Statistical Manual of Mental Disorders (fifth edition)GABA: γ-aminobutyric acidGPCR: G protein-coupled receptor5HT: serotonin (5-hydroxytryptamine)KOR: κ (kappa) opioid receptorLSD: d-lysergic acid diethylamideMDA: methylenedioxy-amphetamineMDMA: 3,4-methylenedioxy-methamphetamineMOR: µ (mu) opioid receptorMPH: methylphenidateNDEWS: National Drug Early Warning SystemNDTA: National Drug Threat AssessmentNE: norepinephrineNIAAA: National Institute on Alcohol Abuse and AlcoholismNIDA: National Institute on Drug AbuseNMDA:N-methyl-D-aspartateOUD: opioid use disorderPCP: phencyclidinepsilocybin: 4-phosphoryloxy-N,N-dimethyltryptaminePTSD: posttraumatic stress disorderSAMSA: Substance Use and Mental Health Services AdministrationSUD: substance use disorder